Fund Holdings — Decheng Capital LLC

Total Portfolio Value
$573.20M
Total Bought
$6.64M
Total Sold
$25.36M
Net Transaction
-$18.73M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
CG ONCOLOGY INC(CGON)6,371,6696,371,6690165,663256,65144.78%+90,987
Nuvation Bio Inc.(NUVB)25,954,43925,954,439050,61196,03116.75%+45,420
Upstream Bio Inc.(UPB)3,285,2933,285,293036,07361,79610.78%+25,724
MERUS NV189,098186,546-2,5529,94717,5633.06%+7,617
Arcus Biosciences, Inc(RCUS)160,000547,609+387,6098117,4471.30%+6,636
Equillium Inc.(EQ)4,447,3084,447,30801,4026,3601.11%+4,958
NEWAMSTERDAM PHARMA CO NV
ORDINARY SHARES
770,000657,051-112,94913,94518,6873.26%+4,742
Lyell Immunopharma, Inc.(LYEL)595,466595,46605,2649,6701.69%+4,406
Aclaris Therapeutics, Inc.(ACRS)4,041,7364,041,73605,7397,6791.34%+1,940
CRINETICS PHARMACEUTICALS IN(CRNX)143,000143,00004,1135,9561.04%+1,843
REVOLUTION MEDICINES INC(NSM)(RVMD)226,000210,000-16,0008,3159,8071.71%+1,492
Zentalis Pharmaceuticals Inc.(ZNTL)1,323,3271,323,32701,5351,9980.35%+463
Pyxis Oncology, Inc (formerly Apexigen)(PYXS)326,810326,81003597260.13%+366
REZOLUTE INC(RZLT)59,90059,90002675630.10%+296
GRAIL INC(GRAL)9,6849,68404985730.10%+75
Illumnia, Inc.(ILMN)7,9797,97907617580.13%-4
Nuvation Bio Inc.(NUVB)646,057646,05701271150.02%-12
Aura Biosciences, Inc.(AURA)515,555515,55503,2273,1860.56%-41
4D MOLECULAR THERAPEUTICS IN239,51092,748-146,7628898060.14%-83
LEGEND BIOTECH CORP-ADR(LEGN)20,0000-20,0007100—-710
AARDVARK THERAPEUTICS INC3,917,2993,917,299052,96252,0619.08%-901
BeyondSpring Inc.(BYSI)4,531,4814,286,104-245,37710,6497,7581.35%-2,891
KRYSTAL BIOTECH INC(KRYS)66,00032,300-33,7009,0725,7020.99%-3,370
ARCELLX INC
COMMON STOCK
547,6090-547,6094,4580—-4,458
MOONLAKE IMMUNOTHERAPEUTICS181,600181,60008,5721,3020.23%-7,269
Page 1 of 1
Decheng Capital LLC — 13F Holdings — Q3 2025 | TickerTrail